81 filings
Page 3 of 5
CORRESP
77ttqkkh
11 Aug 22
Correspondence with SEC
12:00am
UPLOAD
c33oh
11 Aug 22
Letter from SEC
12:00am
S-3
3wb1qhjgfcnxa
8 Aug 22
Shelf registration
5:23pm
8-K
twmuuj3 yyg
8 Aug 22
Rallybio Reports Second Quarter 2022 Financial Results
8:30am
8-K
7adwcb5q5lunj836
2 Aug 22
Rallybio Appoints Wendy K. Chung, M.D., Ph.D., to Its Board of Directors
8:30am
S-8
mya7lp2 e18hl
6 Jun 22
Registration of securities for employees
4:31pm
8-K
vls5zf1l fxt09s
2 Jun 22
Rallybio Announces Retirement of Jeffrey Fryer, CPA, Chief Financial Officer
9:00am
8-K
zbi kph547
27 May 22
Submission of Matters to a Vote of Security Holders
4:00pm
8-K
1t6a77663tqozsajf
10 May 22
Rallybio Reports First Quarter 2022 Financial Results
4:01pm
DEF 14A
r4o2apaele
25 Apr 22
Definitive proxy
5:03pm
8-K
8cqf9cpn5o8leonxs
4 Apr 22
Rallybio Appoints Christine A. Nash and Hui Liu, Ph.D., to Its Board of Directors
8:35am
10-K
hgb7kmlrzdxiyaxrvkr
15 Mar 22
Annual report
4:31pm
8-K
6sa2xxlyw2xp6o dwfr
15 Mar 22
Rallybio Reports Fourth Quarter and Full Year 2021 Financial Results
8:30am
8-K
xs2y2 mzfog2ctfr
7 Mar 22
MARCH 2022 TAKING A DEVASTATING DISEASE – AND DEVASTATING IT. We’re going there. Corporate Presentation
8:00am
8-K
1bj exckucflhckb8eb
10 Nov 21
Rallybio Corporation Reports Third Quarter 2021 Financial Results and Recent Business Highlights
7:32am
10-Q
b1dlmzfg
9 Sep 21
Quarterly report
4:16pm
8-K
agkeq5
9 Sep 21
Rallybio Corporation Reports Second Quarter 2021 Financial Results and Recent Business Highlights
4:11pm